Reuters logo
in 5 months
BRIEF-Resverlogix announces receipt of notice of allowance from the U.S. Patent And Trademark Office
March 15, 2017 / 11:39 AM / in 5 months

BRIEF-Resverlogix announces receipt of notice of allowance from the U.S. Patent And Trademark Office

March 15 (Reuters) - Resverlogix Corp

* Resverlogix announces receipt of notice of allowance from the united states patent and trademark office

* Resverlogix -receipt of notice of allowance from uspto for patent claims covering use of apabetalone in combination with rosuvastatin in united states

* Resverlogix corp says rosuvastatin was exclusively marketed by astrazeneca under trade name crestor until its patent expired in 2016 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below